Financials
- Market Capitalization 7.88 M
- Employee N/A
- Founded 2021
- CEO N/A
- Website www.aspirebiolabs.com
- Headquarter Cayman Islands
- FIGI BBG015STV133
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.32
売上高対価格比率
1 271.75
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4859 | AEON AEON Biopharma, Inc. Class A Common Stock | 0.35 USD | +9.38% | -50.00% | -49.28% | -66.35% | 9.21 M USD | ||
| 4863 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 8.63 USD | +3.48% | +2.25% | +66.60% | -9.24% | 8.20 M USD | ||
| 4881 | ELOX Eloxx Pharmaceuticals, Inc. | 11.41 USD | +0.53% | +4.20% | -23.16% | +14.10% | 7.86 M USD | ||
| 4883 | BOLT Bolt Biotherapeutics, Inc. - Common Stock | 4.05 USD | +7.14% | 0.00% | -14.56% | -31.93% | 7.78 M USD |